(52.14.97.206)
Users online: 15962     
Ijournet
Email id
 

International Journal of Clinical Biochemistry and Research
Year : 2018, Volume : 5, Issue : 2
First page : ( 175) Last page : ( 179)
Print ISSN : 2394-6369. Online ISSN : 2394-6377.
Article DOI : 10.18231/2394-6377.2018.0036

A study of Serum Soluble CD40 Ligand level and its correlation with serum CK-MB and lipid profile in patients with acutecoronary syndrome

Manonmani M.1,*, Velu V. Kuzhandai2, Manimekalai K3

1Assistant Professor, Dept. of Biochemistry, Government Sivagangai, Medical College & Hospital, Sivagangai, Tamil Nadu

2Tutor, Department of Biochemistry, Dept. of Pharmacology, Mahatma Gandhi Medical College & Research Institute, Pillaiyarkuppam, Puducherry, India

3Professor & HOD, Dept. of Pharmacology, Mahatma Gandhi Medical College & Research Institute, Pillaiyarkuppam, Puducherry, India

*Corresponding Author: Email: dr.manonmani2011@gmail.com

Online published on 2 January, 2019.

Abstract

Introduction

Coronary heart disease is an impairment of heart function due to inadequate blood flow to the heart. It is the most common cause of death worldwide. Serum sCD40L is an inflammatory marker. It is released from the platelets as soon as the onset of the chest pain. It is a strong predictor of cardio vascular risk factor.

Objectives

To estimate Serum sCD40Ligand, Serum CK-MB, Serum Lipid Parameters, Serum LDH, and Serum AST levels in patients with ACS.

Materials and Methods

Study group comprised of 50 subjects were admitted in ICCU with ACS. 50 healthy sex and age matched subjects were taken as control groups. Venous blood samples were collected. Serum Soluble CD40Ligand was estimated by ELISA technique, Serum CK-MB estimated by Immunoinhibition method, Serum Lipid profile by enzymatic assay methods. Serum LDH by DKGC method, Serum AST by Modified IFCC method.

Results

There was significant increase in Serum sCD40L(p<0.0001), Serum TC, Serum TGL, Serum LDL-C, Serum VLDL while significant decrease in the Sr. HDL-C levels in the ACS patients compared to control group. There was no significant change in Sr. LDH levels and Sr. AST levels in ACS patients compared to control group. There was a significant positive correlation between Serum sCD40L and Serum CK-MB, Serum TC, Serum TGL, Serum LDL-C, Serum VLDL and a negative correlation between Serum sCD40L and Serum HDL-C while no significant correlation was found between Serum sCD40L with Serum LDH and Serum AST levels.

Conclusion

Serum sCD40L can be used as a marker in individuals with Acute Coronary Artery disease.

Top

Keywords

sCD40L, ACS, MI, CK-MB, Lipid Parameters.

Top

 
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
751,086,744 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.